Because the diagnosis of PAD was confirmed in our patient with NTG, we believe that endothelial dysfunction secondary to PAD could be a probable risk factor for and pathological cause of optic nerve damage in our patient’s case, although this probable effect should be confirmed in future studies. The gene discussed is OPA1; the disease is peripheral arterial disease.